Suggestions
Babi Wadhwani
Professional Background
Babi Wadhwani is an accomplished clinical operations professional, recognized for her extensive experience and expertise in managing clinical trials from First-In-Human (FIH) stages to late-stage trials, as well as overseeing New Drug Application (NDA) and Biologics License Application (BLA) submissions, along with post-marketing commitments. With a robust background in diverse therapeutic areas including oncology, HIV, cardiovascular diseases, rare diseases, and most recently, psychedelic drug development, Babi stands out for her ability to lead cross-functional teams toward achieving project goals in highly regulated environments.
Throughout her career, Babi has demonstrated a strong commitment to clinical excellence and has built a reputation for consistently meeting and exceeding challenging timelines. As a senior director at Usona Institute, she spearheads clinical development efforts working on innovative therapies aimed at improving patient outcomes. Her leadership philosophy emphasizes collaboration, communication, and strategic foresight, enabling her teams to thrive in fast-paced settings. Babi's involvement in clinical operations has not only contributed to her organizations' successes but has also profoundly impacted the advancement of medical science.
Education and Achievements
Babi Wadhwani's educational journey laid a strong foundation for her career in clinical operations. She earned her Master of Public Health (MPH) in Public Health Education and Promotion from Loma Linda University, where she honed her skills in health communication and community engagement. She further deepened her knowledge in cancer research through a Certificate Program in the Minority Training Program in Cancer Control Research at the University of California, San Francisco. Additionally, she completed her Bachelor's Degree in Biology from the University of California, Santa Cruz, which provided her with a comprehensive understanding of biological sciences essential for her work in clinical trials.
Babi's educational achievements are complemented by an impressive professional trajectory marked by leadership roles at leading biopharmaceutical companies. Prior to her current position, she served as the Director of Clinical Operations at BioMarin Pharmaceutical Inc., where she played a pivotal role in advancing treatments for rare genetic disorders. At Portola Pharmaceuticals, as the Director of Clinical Operations, Babi was instrumental in the successful execution of clinical studies and regulatory submissions that propelled the company forward in the competitive pharmaceutical landscape.
Her earlier experiences as an Associate Director at both Medivation and Onyx Pharmaceuticals, an Amgen subsidiary, equipped her with a wealth of knowledge in drug development processes and regulatory requirements. Babi also excelled in her role as a Clinical Program Manager at Gilead Sciences, where she managed significant global trials, leading her teams through the complexities of late-stage drug development.
Notable Contributions
Throughout her career, Babi Wadhwani has demonstrated a steadfast dedication to the advancement of clinical research. Her ability to lead and mentor teams in a collaborative environment has been instrumental in driving success across multiple projects. Babi's profound understanding of clinical study design, execution, and regulatory compliance has resulted in numerous successful product launches, helping to bring much-needed therapies to market.
In addition to her operational leadership, Babi has contributed to various scientific publications and presentations, showcasing her expertise and insights into the evolving landscape of clinical operations. She remains actively engaged in professional development and industry conferences, staying abreast of the latest innovations and best practices in clinical research.
Babi Wadhwani's career encapsulates a wealth of experience, from her early days as a Clinical Research Associate to her current leadership role as Senior Director of Clinical Development at Usona Institute. Her journey highlights her resilience, expertise, and passion for enhancing patient care through rigorous clinical trials and strategic operational management.
